3 Hot Penny Stocks to Add to Your Small Cap Watchlist This Week | News
Are these Penny Stocks on your watch list this coming week?
There are several ways to find penny stocks that may be worth buying. When looking for penny stocks to buy, understanding exactly what is going on in the stock market is crucial. Because penny stocks are so speculative, they tend to move frequently with news, announcements, or press releases. For this reason, it is crucial to be aware of all the latest news surrounding a company before investing in its penny stock.
When it comes to buying small caps, there are a few specific strategies you can use to find penny stocks that may be worth buying. But before that, investors should have a solid understanding of their own investment strategy and risk tolerance. This will allow you to weed out penny stocks that don’t fit your investment philosophy. With penny stocks, risk is an inherent factor to consider. This is why many conservative investors tend to avoid them.
[Read More] Penny Stocks trend to buy next month? 3 to watch in May
But, for those willing to take a little more risk, penny stocks can offer the potential for huge rewards. And with so many different companies to choose from, there are penny stocks for every type of investor. So always make sure you understand exactly what a company does, how volatile it is, and what its fundamentals look like. With that in mind, let’s take a look at three penny stocks to add to your watchlist right now.
3 Penny Stocks to Add to Your Watchlist This Week
- Clarus Therapeutics Holdings Inc. (NASDAQ: CRXT)
- Borqs Technologies Inc. (NASDAQ: BRQS)
- Petros Pharmaceuticals Inc. (NASDAQ: PTPI)
Clarus Therapeutics Holdings Inc. (NASDAQ: CRXT)
After a 180% gain in the April 19-April 20 period, CRXT shares have been on many investors’ radars. Despite a 20% decline on April 22, it is clear that there is quite a significant bullish sentiment. The main reason for this is that the company announced new data for JATENZO as well as its quarterly results a few weeks earlier.
As for the former, CRXT has announced JATENZO, which is the first FDA-approved oral soft gel for testosterone therapy in adult men. In its fourth quarter and full year results, the company reported a year-over-year increase in net revenue of 119% or $14 million. And, he reported that fourth-quarter net revenue was up more than 88% year-over-year, which is no small feat.
“Clarus recorded solid net sales growth as a new public company, driven by continued demand for JATENZO. We have also significantly expanded payer access coverage for JATENZO, as payers have recognized its value and innovation for the treatment of appropriate hypogonadal men. In February, we launched our new online patient portal, in partnership with Vault Health and AssistRx, leaders in providing patient health services.
Clarus CEO, Dr. Robert Dudley
With its exciting gains over the past few weeks, Clarus Therapeutics remains an interesting penny stock to watch. Whether it’s worth adding to your list of penny stocks to buy, however, is up to you.
Borqs Technologies Inc. (NASDAQ: BRQS)
Another penny stock that has seen substantial gains recently is the BRQS stock. Over the past five days, shares of BRQS have soared more than 55%. This is no small feat and shows exactly how much bullish sentiment reigns around Borqs Technologies.
The company’s most recent news came on April 14 when it announced that it had successfully purchased a 5G license with Qualcomm. This license will allow it to produce 5G products based on Qualcomm technology. And because 5G has become so popular over the past year, there is a tremendous amount of opportunity in this market.
[Read More] Best Penny Stocks, How to Buy and Strategies for Beginners
If you are unfamiliar, Borqs Technology is a leader in IoT software and products. This includes a chipset software library, Android enhancements, and 5G products for phones and hotspots. In addition, the company recently acquired a majority stake in a national solar power system company. So with that in mind, do you think BRQS stock is worth adding to your penny stocks watchlist or not?
Petros Pharmaceuticals Inc. (NASDAQ: PTPI)
With a five-day gain of more than 14%, Petros Pharmaceuticals has continued to attract attention over the past few weeks. And despite being down more than 55% year-on-year, there has been a significant recent bullish reversal with PTPI stocks. With an increase of more than 40% just a few days ago, the main news with PTPI comes from the announcement of positive results for its over-the-counter erectile dysfunction drug known as STENDRA.
“The results of this label comprehension study help us continue to solidify our plans to apply to the FDA to help expand access to STENDRA beyond the prescription model and, if approved by the FDA, to make STENDRA potentially the first emergency-grade prescription medication to become available over-the-counter in the United States.
Petros CCO, Fady Boctor
If he is able to gain OTC status for this compound, it is unclear what potential Petros may have in the future. Considering that, do you think it’s worth buying next month?
Are Penny Stocks Worth Buying?
Finding the best penny stocks to buy can be a daunting task for any investor, especially for newcomers to the stock market. However, with a little research and due diligence, it is possible to find penny stocks that have the potential to generate profits. factors, including company finances, business.
[Read More] Can you buy Penny Stocks in an IRA? The answer might surprise you
When looking for penny stocks to buy, it’s important to consider a number of factors. This includes reviewing the company’s balance sheet, income statement, and cash flow statement. By doing this, you can get a better idea of the overall financial health of the business. So with all of that in mind, do you think penny stocks are worth buying or not?